315 related articles for article (PubMed ID: 31866016)
1. European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2019.
Garbe C; Amaral T; Peris K; Hauschild A; Arenberger P; Bastholt L; Bataille V; Del Marmol V; Dréno B; Fargnoli MC; Grob JJ; Höller C; Kaufmann R; Lallas A; Lebbé C; Malvehy J; Middleton M; Moreno-Ramirez D; Pellacani G; Saiag P; Stratigos AJ; Vieira R; Zalaudek I; Eggermont AMM;
Eur J Cancer; 2020 Feb; 126():159-177. PubMed ID: 31866016
[TBL] [Abstract][Full Text] [Related]
2. European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022.
Garbe C; Amaral T; Peris K; Hauschild A; Arenberger P; Basset-Seguin N; Bastholt L; Bataille V; Del Marmol V; Dréno B; Fargnoli MC; Forsea AM; Grob JJ; Hoeller C; Kaufmann R; Kelleners-Smeets N; Lallas A; Lebbé C; Lytvynenko B; Malvehy J; Moreno-Ramirez D; Nathan P; Pellacani G; Saiag P; Stratigos AJ; Van Akkooi ACJ; Vieira R; Zalaudek I; Lorigan P;
Eur J Cancer; 2022 Jul; 170():256-284. PubMed ID: 35623961
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2016.
Garbe C; Peris K; Hauschild A; Saiag P; Middleton M; Bastholt L; Grob JJ; Malvehy J; Newton-Bishop J; Stratigos AJ; Pehamberger H; Eggermont AM; ; ;
Eur J Cancer; 2016 Aug; 63():201-17. PubMed ID: 27367293
[TBL] [Abstract][Full Text] [Related]
4. European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics - Update 2019.
Garbe C; Amaral T; Peris K; Hauschild A; Arenberger P; Bastholt L; Bataille V; Del Marmol V; Dréno B; Fargnoli MC; Grob JJ; Höller C; Kaufmann R; Lallas A; Lebbé C; Malvehy J; Middleton M; Moreno-Ramirez D; Pellacani G; Saiag P; Stratigos AJ; Vieira R; Zalaudek I; Eggermont AMM;
Eur J Cancer; 2020 Feb; 126():141-158. PubMed ID: 31928887
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline--Update 2012.
Garbe C; Peris K; Hauschild A; Saiag P; Middleton M; Spatz A; Grob JJ; Malvehy J; Newton-Bishop J; Stratigos A; Pehamberger H; Eggermont AM; ; ;
Eur J Cancer; 2012 Oct; 48(15):2375-90. PubMed ID: 22981501
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline.
Garbe C; Peris K; Hauschild A; Saiag P; Middleton M; Spatz A; Grob JJ; Malvehy J; Newton-Bishop J; Stratigos A; Pehamberger H; Eggermont A
Eur J Cancer; 2010 Jan; 46(2):270-83. PubMed ID: 19959353
[TBL] [Abstract][Full Text] [Related]
7. European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022.
Garbe C; Amaral T; Peris K; Hauschild A; Arenberger P; Basset-Seguin N; Bastholt L; Bataille V; Del Marmol V; Dréno B; Fargnoli MC; Forsea AM; Grob JJ; Höller C; Kaufmann R; Kelleners-Smeets N; Lallas A; Lebbé C; Lytvynenko B; Malvehy J; Moreno-Ramirez D; Nathan P; Pellacani G; Saiag P; Stratigos AJ; Van Akkooi ACJ; Vieira R; Zalaudek I; Lorigan P;
Eur J Cancer; 2022 Jul; 170():236-255. PubMed ID: 35570085
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline.
Stratigos A; Garbe C; Lebbe C; Malvehy J; del Marmol V; Pehamberger H; Peris K; Becker JC; Zalaudek I; Saiag P; Middleton MR; Bastholt L; Testori A; Grob JJ; ; ;
Eur J Cancer; 2015 Sep; 51(14):1989-2007. PubMed ID: 26219687
[TBL] [Abstract][Full Text] [Related]
9. Head and neck melanoma (excluding ocular melanoma): United Kingdom National Multidisciplinary Guidelines.
Ahmed OA; Kelly C
J Laryngol Otol; 2016 May; 130(S2):S133-S141. PubMed ID: 27841141
[TBL] [Abstract][Full Text] [Related]
10. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment.
Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Concetta Fargnoli M; Forsea AM; Frenard C; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NWJ; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
Eur J Cancer; 2020 Mar; 128():83-102. PubMed ID: 32113942
[TBL] [Abstract][Full Text] [Related]
11. Patient-reported outcomes in patients with resected, high-risk melanoma with BRAF
Schadendorf D; Hauschild A; Santinami M; Atkinson V; Mandalà M; Chiarion-Sileni V; Larkin J; Nyakas M; Dutriaux C; Haydon A; Robert C; Mortier L; Lesimple T; Plummer R; Schachter J; Dasgupta K; Manson S; Koruth R; Mookerjee B; Kefford R; Dummer R; Kirkwood JM; Long GV
Lancet Oncol; 2019 May; 20(5):701-710. PubMed ID: 30928620
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline.
Lebbe C; Becker JC; Grob JJ; Malvehy J; Del Marmol V; Pehamberger H; Peris K; Saiag P; Middleton MR; Bastholt L; Testori A; Stratigos A; Garbe C;
Eur J Cancer; 2015 Nov; 51(16):2396-403. PubMed ID: 26257075
[TBL] [Abstract][Full Text] [Related]
13. Malignant melanoma S3-guideline "diagnosis, therapy and follow-up of melanoma".
Pflugfelder A; Kochs C; Blum A; Capellaro M; Czeschik C; Dettenborn T; Dill D; Dippel E; Eigentler T; Feyer P; Follmann M; Frerich B; Ganten MK; Gärtner J; Gutzmer R; Hassel J; Hauschild A; Hohenberger P; Hübner J; Kaatz M; Kleeberg UR; Kölbl O; Kortmann RD; Krause-Bergmann A; Kurschat P; Leiter U; Link H; Loquai C; Löser C; Mackensen A; Meier F; Mohr P; Möhrle M; Nashan D; Reske S; Rose C; Sander C; Satzger I; Schiller M; Schlemmer HP; Strittmatter G; Sunderkötter C; Swoboda L; Trefzer U; Voltz R; Vordermark D; Weichenthal M; Werner A; Wesselmann S; Weyergraf AJ; Wick W; Garbe C; Schadendorf D; ;
J Dtsch Dermatol Ges; 2013 Aug; 11 Suppl 6():1-116, 1-126. PubMed ID: 24028775
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAF
Dummer R; Brase JC; Garrett J; Campbell CD; Gasal E; Squires M; Gusenleitner D; Santinami M; Atkinson V; Mandalà M; Chiarion-Sileni V; Flaherty K; Larkin J; Robert C; Kefford R; Kirkwood JM; Hauschild A; Schadendorf D; Long GV
Lancet Oncol; 2020 Mar; 21(3):358-372. PubMed ID: 32007138
[TBL] [Abstract][Full Text] [Related]
15. SEOM guidelines for the management of Malignant Melanoma 2015.
Berrocal A; Arance A; Espinosa E; Castaño AG; Cao MG; Larriba JL; Martín JA; Márquez I; Soria A; Algarra SM
Clin Transl Oncol; 2015 Dec; 17(12):1030-5. PubMed ID: 26669314
[TBL] [Abstract][Full Text] [Related]
16. Mutation Testing and Adjuvant Systemic Therapy in Cutaneous Melanoma.
Olszanski AJ
J Natl Compr Canc Netw; 2019 May; 17(5.5):615-617. PubMed ID: 31117032
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant therapy of malignant melanoma and the role of sentinel node mapping.
Eggermont AM
Recent Results Cancer Res; 2000; 157():178-89. PubMed ID: 10857171
[TBL] [Abstract][Full Text] [Related]
18. European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment-Update 2023.
Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; van Akkooi A; Bataille V; Bastholt L; Dreno B; Dummer R; Fargnoli MC; Forsea AM; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NW; Lallas A; Leiter U; Malvehy J; Del Marmol V; Moreno-Ramirez D; Pellacani G; Peris K; Saiag P; Tagliaferri L; Trakatelli M; Ioannides D; Vieira R; Zalaudek I; Arenberger P; Eggermont AMM; Röcken M; Grob JJ; Lorigan P;
Eur J Cancer; 2023 Nov; 193():113252. PubMed ID: 37708630
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma.
Long GV; Hauschild A; Santinami M; Atkinson V; Mandalà M; Chiarion-Sileni V; Larkin J; Nyakas M; Dutriaux C; Haydon A; Robert C; Mortier L; Schachter J; Schadendorf D; Lesimple T; Plummer R; Ji R; Zhang P; Mookerjee B; Legos J; Kefford R; Dummer R; Kirkwood JM
N Engl J Med; 2017 Nov; 377(19):1813-1823. PubMed ID: 28891408
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial.
Amaria RN; Prieto PA; Tetzlaff MT; Reuben A; Andrews MC; Ross MI; Glitza IC; Cormier J; Hwu WJ; Tawbi HA; Patel SP; Lee JE; Gershenwald JE; Spencer CN; Gopalakrishnan V; Bassett R; Simpson L; Mouton R; Hudgens CW; Zhao L; Zhu H; Cooper ZA; Wani K; Lazar A; Hwu P; Diab A; Wong MK; McQuade JL; Royal R; Lucci A; Burton EM; Reddy S; Sharma P; Allison J; Futreal PA; Woodman SE; Davies MA; Wargo JA
Lancet Oncol; 2018 Feb; 19(2):181-193. PubMed ID: 29361468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
